April 22, 2023 Comments Off on New patent for Chemocentryx drug TAVNEOS Posted in: Patent Added Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Chemocentryx drug TAVNEOS appeared first on D…
April 22, 2023 Comments Off on New patent for Esperion Theraps drug NEXLETOL Posted in: Patent Added Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Esperion Theraps drug NEXLETOL appeared first on DrugP…